The Sandler-Kenner Foundation’s primary focus is to improve survivability of pancreatic cancer patients by developing early identification tools that are highly sensitive, cost effective and easily implemented by medical practitioners. The Foundation is also committed to raising awareness of adenocarcinoma and neuroendocrine pancreatic cancers.
The prognosis of pancreatic cancer has not improved in the last 50 years, with the average survival after diagnosis being three to six months. Symptoms of pancreatic cancer typically occur only at an advanced stage, leaving patients with limited treatment options.
The Sandler-Kenner Foundation is a 501(c)(3) charitable organization. All donations made to Sandler-Kenner Foundation are tax-deductible to the extent allowed by law.